Delivery Order SPE2DR25D2104-SPE2DR26F3PUM
Award Date 11/24/25
Potential Completion Date 11/25/25
Potential Value $6.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $48,976.20 delivery order to AmerisourceBergen Drug Corp for Mounjaro (tirzepatide) 10 mg/0.5 mL pen injections on September 12, 2025, with completion targeted for September 15, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Mounjaro is a GLP-1 receptor agonist medication used for diabetes management,...
- The Defense Logistics Agency awarded a $61,157.01 delivery order to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pen injectors on November 24, 2025, with an ultimate completion date of November 25, 2025. This competitively awarded, firm fixed-price delivery order contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a tirzepatide injection used for diabetes management, reflecting the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro (tirzepatide) 7.5 mg/0.5 mL pen injections, with a contract ceiling value of $6,235.50. This competitively awarded, firm fixed-price delivery order was issued on August 4, 2025, with an ultimate completion date of August 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp valued at $30,465.45 for Mounjaro 5 mg/0.5 ml pen injections on December 10, 2025, with a completion date of December 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a tirzepatide-based pharmaceutical used for diabetes management, consistent with...
- The Defense Logistics Agency awarded a delivery order valued at $4,252.48 to AmerisourceBergen Drug Corp for Mounjaro (tirzepatide) 7.5 mg/0.5 mL pen injectors on October 28, 2025, with completion targeted for October 29, 2025. This non-competitive delivery order carries firm fixed pricing and will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical supply vendor, AmerisourceBergen Drug Corp...
- The Defense Logistics Agency awarded a delivery order valued at $4,616.23 to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 mL pen injections on December 9, 2025, with completion scheduled for December 10, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a tirzepatide-based medication used for diabetes management, reflecting the...
- The Defense Logistics Agency awarded a $1,632.54 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Mounjaro (tirzepatide) 7.5 mg/0.5 mL pens with a completion date of July 22, 2025. This firm fixed price delivery order is unclassified with no set-aside provisions and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a GLP-1 receptor agonist indicated for diabetes management, representing part of the...
- The Defense Logistics Agency awarded a delivery order valued at $1,170.98 to AmerisourceBergen Drug Corp for the supply of Mounjaro (tirzepatide) 12.5 mg/0.5 mL pen injections on August 29, 2025, with completion scheduled for September 2, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through the federal procurement process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order valued at $1,580.52 to AmerisourceBergen Drug Corp for Mounjaro (tirzepatide) 7.5 mg/0.5 mL pen injections on December 8, 2025, with completion scheduled for December 9, 2025. This competitively awarded, firm fixed-price contract requires no set-aside designation and will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $7,501.37 delivery order to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 mL pens on December 9, 2025, with completion targeted for December 10, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. Mounjaro is a tirzepatide injection used primarily for diabetes management, representing a critical pharmaceutical supply for military...